Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · IEX Real-Time Price · USD
1.47
-0.07 (-4.55%)
At close: May 20, 2022 4:00 PM
1.46
-0.01 (-0.68%)
After-hours:May 20, 2022 7:56 PM EDT

Cash Flow Statement (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-12-31
Net Income
-44.67-40.34-28.19-17.9-10.3-6.39---5.78
Depreciation & Amortization
-1.62-0.58-0.08--0.07
Share-Based Compensation
-0.65-0.27-0.23--0.08
Other Operating Activities
44.677.2528.195.8610.30.3100-0.59
Operating Cash Flow
--30.82--11.2--5.77---6.22
Capital Expenditures
--1.07--1.71--2.31---2.74
Investing Cash Flow
--1.07--1.71--2.31---2.74
Share Issuance / Repurchase
-44.18-0-0--0
Debt Issued / Paid
-28.16-14.53-7.45--5
Other Financing Activities
000000003.7
Financing Cash Flow
-72.33-14.53-7.45--8.7
Net Cash Flow
-40.44-1.62--0.63---0.25
Free Cash Flow
--31.89--12.91--8.08---8.95
Free Cash Flow Margin
---184414.29%-----49738.89%
Free Cash Flow Per Share
--2.46--2.47--0.81---1.89
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).